These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


132 related items for PubMed ID: 7453534

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Reflections on medicamentous liver-therapy. Hepavis in medical practice].
    Wegener W.
    Med Monatsschr; 1977 Jul; 31(7):328-30. PubMed ID: 904570
    [No Abstract] [Full Text] [Related]

  • 3. [Clinical experience with the oral liver-therapeutic agent Hepavis].
    Bayazid A, Gerhard W.
    Med Welt; 1976 Nov 12; 27(46):2248-9. PubMed ID: 794616
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Treatment of alcoholic toxic fatty liver. A placebo-controlled trial with hepavis (author's transl)].
    Deynet G, Reimer F.
    MMW Munch Med Wochenschr; 1979 Jun 15; 121(24):831-2. PubMed ID: 111085
    [Abstract] [Full Text] [Related]

  • 7. [Clinical investigation of silymarin in chronic liver diseases (author's transl)].
    Realini S, Gonvers JJ, Hofstetter JR.
    Schweiz Rundsch Med Prax; 1975 May 13; 64(19):595-8. PubMed ID: 51497
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Clinical experimentation with Aïcamine in hepatic insufficiency].
    Négret JP.
    Bord Med; 1972 Apr 13; 5(8):973-6. PubMed ID: 5053280
    [No Abstract] [Full Text] [Related]

  • 11. [Possibilities of the treatment of chronic liver diseases with and without vitamin B 12 -folic acid administration].
    Börner E.
    Med Welt; 1972 Aug 05; 23(31):1077-80. PubMed ID: 4647306
    [No Abstract] [Full Text] [Related]

  • 12. [Therapeutic progress in chronic liver diseases].
    Wildhirt E.
    Dtsch Z Verdau Stoffwechselkr; 1968 Aug 05; 28(2):207-8. PubMed ID: 4894834
    [No Abstract] [Full Text] [Related]

  • 13. Therapeutic trial with methylphenobarbital (Prominal), an enzyme inducer, in liver disease. A contribution to the question of hepatotoxicity of barbiturates.
    Glogner P, Massarrat S, Henrichs HR.
    Acta Hepatosplenol; 1971 Aug 05; 18(5):394-7. PubMed ID: 5112056
    [No Abstract] [Full Text] [Related]

  • 14. [Clinical studies on the liver-protective effect of 4-amino-5-imidazole carboxamide and orotic acid].
    Fehér VJ, Jakab L, Tenczer J, Szilvási I.
    Dtsch Z Verdau Stoffwechselkr; 1977 Aug 05; 37(4):175-9. PubMed ID: 75788
    [No Abstract] [Full Text] [Related]

  • 15. [Drug therapy of liver diseases with Hepatofalk].
    Hirsch W, Smerlings H.
    Ther Ggw; 1976 Oct 05; 115(10):1719-54. PubMed ID: 136762
    [No Abstract] [Full Text] [Related]

  • 16. [On the therapy of liver diseases with ornithine aspartate].
    Melzer H, Weber D, Wotzka R.
    Med Klin; 1969 Oct 05; 64(35):1541-4. PubMed ID: 5354488
    [No Abstract] [Full Text] [Related]

  • 17. [Therapeutic effect of a preparation of total liver extract, cyanocobalamin and amino acids of the Krebs cycle, in acute and chronic liver diseases].
    Pignattari S, Sarti F, Toscano S, Dal Monte PR.
    Minerva Med; 1972 Jul 11; 63(53):2861-72. PubMed ID: 5049878
    [No Abstract] [Full Text] [Related]

  • 18. [Further clinical experiences with ornithine aspartate in liver diseases].
    Wotzka R, Weber D.
    Ther Ggw; 1972 Mar 11; 111(3):400-12. PubMed ID: 5024593
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Controlled clinical trial of a new combination of phosphorylcholine, homocysteine-gamma-thiolactone and vitamin B 12 in the parenteral treatment of chronic hepatopathies].
    Bandini S, Monteforte S.
    Clin Ter; 1974 Jun 30; 69(6):549-60. PubMed ID: 4845637
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.